Experts debate the gamble by Quebec, Alberta and Manitoba on a vaccine lottery capitalcurrent.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalcurrent.ca Daily Mail and Mail on Sunday newspapers.
HALIFAX Some Maritime researchers are helping to identify and deal with rare, but serious, side-effects that some people have after getting a COVID-19 vaccine, and say their work should be reassuring, not unsettling to Canadians. In an early morning news release Tuesday, the federal COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group announced an investment of $800,000 for a study to further improve Canada s identification and response to adverse events people may experience following COVID-19 vaccination across 10 provinces. This study is an extension of an existing vaccine safety program that provides important public health information about adverse events following immunization for all vaccines authorized for use in adults and children, according to the release.
Dr. Volker Gerdts, director of VIDO-InterVac. (University of Saskatchewan)
The COVID-19 vaccine created by Saskatoon’s Vaccine and Infectious Disease Organization (VIDO) has been demonstrated as safe and effective in its Phase One clinical trials.
The interim data results come from the Canadian Centre for Vaccinology, and show the most common side effects reported were headaches and pain at the injection site. It’s not clear whether one or two doses need to be administered.
According to VIDO, even low doses of the vaccine were highly effective, although there’s no information from VIDO to indicate percentages at this point.
Positive Phase 1 results for COVAC-2 announced newsoptimist.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsoptimist.ca Daily Mail and Mail on Sunday newspapers.